ASX
Telix Pharmaceuticals
TLX:ASX•Healthcare
Sensitive ASX Announcement
Telix Achieves FY25 Guidance - US$804M, Q4 Growth
Published: 20/01/26, 05:07pm (AEST)•6 pages